Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility.

Khalil, I; Deschamps, I; Lepage, V; al-Daccak, R; Degos, L; Hors, J

Khalil, I; Deschamps, I; Lepage, V; al-Daccak, R; Degos, L; Hors, J.

Affiliation

Khalil I; Institut National de la Sante et de la Recherche Medicale (INSERM) U93, Saint Louis Hospital, Paris, France.

Diabetes ; 41(3): 378-84, 1992 Mar.

Article in En | MEDLINE | ID: mdl-1551498

Subject(s)

Diabetes Mellitus, Type 1/immunology; HLA-DQ Antigens/genetics; Alleles; Amino Acid Sequence; Base Sequence; Cell Line; DNA/genetics; DNA/isolation & purification; Diabetes Mellitus, Type 1/genetics; Disease Susceptibility; Gene Frequency; Genotype; HLA-D Antigens/genetics; Haplotypes; Histocompatibility Testing; Humans; Macromolecular Substances; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotide Probes; Polymerase Chain Reaction/methods; Reference Values; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HLA-DQ Antigens / Diabetes Mellitus, Type 1 Type of study: Etiology_studies Limits: Humans Language: En Journal: Diabetes Year: 1992 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links